These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15726716)

  • 1. Intensive diabetes control results in less nerve damage.
    Health News; 2005 Jan; 11(1):14. PubMed ID: 15726716
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetic neuropathy].
    Chudzik W; Kaczorowska B; Przybyła M; Chudzik B; Gałka M
    Pol Merkur Lekarski; 2007 Jan; 22(127):66-9. PubMed ID: 17477095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The difficult task of glycaemic control in diabetics with acute coronary syndromes: finding the way to normoglycaemia avoiding both hyper- and hypoglycaemia.
    Abbate A; Biondi-Zoccai GG
    Eur Heart J; 2005 Jul; 26(13):1245-8. PubMed ID: 15914500
    [No Abstract]   [Full Text] [Related]  

  • 4. Exercise training can modify the natural history of diabetic peripheral neuropathy.
    Balducci S; Iacobellis G; Parisi L; Di Biase N; Calandriello E; Leonetti F; Fallucca F
    J Diabetes Complications; 2006; 20(4):216-23. PubMed ID: 16798472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological mechanisms involved in diabetic neuropathy: can we slow the process?
    Sima AA
    Curr Opin Investig Drugs; 2006 Apr; 7(4):324-37. PubMed ID: 16625819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A heart remembers. Another reason tight control matters.
    Gottlieb SH
    Diabetes Forecast; 2005 Nov; 58(11):27, 30-1. PubMed ID: 16350263
    [No Abstract]   [Full Text] [Related]  

  • 7. An overview of what diabetes can do to your body (and what you can do to prevent it).
    Gebel E
    Diabetes Forecast; 2008 Dec; 61(12):45-6. PubMed ID: 19145747
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycaemic control reduces incidence of morbidity.
    Elder Care; 1994; 6(6):33. PubMed ID: 7804175
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diabetes mellitus--from basic research to quality-oriented routine therapy].
    Badenhoop K
    Med Klin (Munich); 2003 Apr; 98(5):241. PubMed ID: 12822556
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetes care: zeroing in on neuropathy.
    Johns Hopkins Med Lett Health After 50; 2005 Nov; 17(9):4-5. PubMed ID: 16294381
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of lisinopril on diabetic peripheral neuropathy: experiment with rats].
    Han LP; Yu DM; Xie Y
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2513-5. PubMed ID: 19080636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
    J Am Coll Cardiol; 2009 Jan; 53(3):298-304. PubMed ID: 19147051
    [No Abstract]   [Full Text] [Related]  

  • 13. C-Peptide reverses nociceptive neuropathy in type 1 diabetes.
    Kamiya H; Zhang W; Ekberg K; Wahren J; Sima AA
    Diabetes; 2006 Dec; 55(12):3581-7. PubMed ID: 17130507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood glucose concentration and outcome of critical illness: the impact of diabetes.
    Egi M; Bellomo R; Stachowski E; French CJ; Hart GK; Hegarty C; Bailey M
    Crit Care Med; 2008 Aug; 36(8):2249-55. PubMed ID: 18664780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in nerve conduction following treatment in newly diagnosed diabetics.
    Ward JD; Barnes CG; Fisher DJ; Jessop JD; Baker RW
    Lancet; 1971 Feb; 1(7696):428-30. PubMed ID: 4100402
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral magnesium administration prevents thermal hyperalgesia induced by diabetes in rats.
    Hasanein P; Parviz M; Keshavarz M; Javanmardi K; Mansoori M; Soltani N
    Diabetes Res Clin Pract; 2006 Jul; 73(1):17-22. PubMed ID: 16417942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats.
    Ueta K; Ishihara T; Matsumoto Y; Oku A; Nawano M; Fujita T; Saito A; Arakawa K
    Life Sci; 2005 Apr; 76(23):2655-68. PubMed ID: 15792833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
    Dave GS; Kalia K
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of foot temperature in diabetic neuropathy: is it another piece of puzzle?
    Naicker AS; Roohi SA; Lee CS; Chan WH; Tay LS; Din XJ; Eow LH
    Med J Malaysia; 2006 Feb; 61 Suppl A():10-3. PubMed ID: 17042221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of the diabetic neuropathies.
    Watkins PJ
    Q J Med; 1990 Dec; 77(284):1209-18. PubMed ID: 2290917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.